betulinic acid has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kowalczyk, T; Picot, L; Sitarek, P; Skała, E; Śliwiński, T; Toma, M; Wielanek, M | 1 |
| Ehrhardt, H; Fulda, S; Höfig, I; Jeremias, I; Obexer, P; Terziyska, N; Wachter, F | 1 |
2 other study(ies) available for betulinic acid and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
An Extract of Transgenic Senna obtusifolia L. Hairy Roots with Overexpression of PgSS1 Gene in Combination with Chemotherapeutic Agent Induces Apoptosis in the Leukemia Cell Line.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Betulinic Acid; Doxorubicin; Farnesyl-Diphosphate Farnesyltransferase; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Green Fluorescent Proteins; Humans; Leukemia; Membrane Potential, Mitochondrial; Panax; Pentacyclic Triterpenes; Plant Proteins; Plant Roots; Plants, Genetically Modified; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Senna Extract; Senna Plant | 2020 |
NOXA as critical mediator for drug combinations in polychemotherapy.
Topics: Animals; Antineoplastic Agents; Betulinic Acid; Cell Death; Child; Doxorubicin; Drug Combinations; Drug Therapy, Combination; Humans; Jurkat Cells; Mice; Mice, Inbred NOD; Mice, SCID; Pentacyclic Triterpenes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-bcl-2; Triterpenes; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vincristine | 2012 |